IFNG and melanoma: Indeed, IFN-γ signaling is frequently down-regulated in melanoma and seems important for the response to anti-CTLA4 and anti-PD1 therapies [3,4] but might play a dual role in melanoma or other types of cancers (pro- or anti-tumorigenic) [4,7,8,9,10,11,12].